rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2010-2-3
|
pubmed:abstractText |
The aim of the study was to define the cost-effectiveness of whole-body (18)F-FDG PET, as compared with chest CT, in screening for distant metastases in patients with head and neck squamous cell carcinoma (HNSCC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1535-5667
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
176-82
|
pubmed:meshHeading |
pubmed-meshheading:20124045-Adult,
pubmed-meshheading:20124045-Aged,
pubmed-meshheading:20124045-Aged, 80 and over,
pubmed-meshheading:20124045-Carcinoma, Squamous Cell,
pubmed-meshheading:20124045-Cost-Benefit Analysis,
pubmed-meshheading:20124045-Costs and Cost Analysis,
pubmed-meshheading:20124045-Diagnostic Errors,
pubmed-meshheading:20124045-Female,
pubmed-meshheading:20124045-Fluorine Radioisotopes,
pubmed-meshheading:20124045-Fluorodeoxyglucose F18,
pubmed-meshheading:20124045-Head and Neck Neoplasms,
pubmed-meshheading:20124045-Humans,
pubmed-meshheading:20124045-Male,
pubmed-meshheading:20124045-Middle Aged,
pubmed-meshheading:20124045-Positron-Emission Tomography,
pubmed-meshheading:20124045-Prospective Studies,
pubmed-meshheading:20124045-Radiopharmaceuticals,
pubmed-meshheading:20124045-Tomography, X-Ray Computed
|
pubmed:year |
2010
|
pubmed:articleTitle |
Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.
|
pubmed:affiliation |
Institute for Medical Technology Assessment, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. uyl@bmg.eur.nl
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|